GB201120711D0 - Method for classifying tumour cells - Google Patents
Method for classifying tumour cellsInfo
- Publication number
- GB201120711D0 GB201120711D0 GBGB1120711.5A GB201120711A GB201120711D0 GB 201120711 D0 GB201120711 D0 GB 201120711D0 GB 201120711 A GB201120711 A GB 201120711A GB 201120711 D0 GB201120711 D0 GB 201120711D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- classifying
- tumour cells
- classes
- nsclc
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G01N33/5752—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a method for preparing an optimised gene signature for assigning a NSCLC sample to one or more NSCLC classes, comprising subjecting a gene signature set forth in Table 12 herein to nearest shrunken centroid analysis to identify one or more subgroups of gene classifiers corresponding to one or more of classes 1 to 6 identified in Table 12, and validating the performance of the selected classifiers by K-fold or leave-one-out cross-validation.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1120711.5A GB201120711D0 (en) | 2011-12-01 | 2011-12-01 | Method for classifying tumour cells |
| PCT/EP2012/004957 WO2013079215A1 (en) | 2011-12-01 | 2012-11-30 | Method for classifying tumour cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1120711.5A GB201120711D0 (en) | 2011-12-01 | 2011-12-01 | Method for classifying tumour cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201120711D0 true GB201120711D0 (en) | 2012-01-11 |
Family
ID=45509031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1120711.5A Ceased GB201120711D0 (en) | 2011-12-01 | 2011-12-01 | Method for classifying tumour cells |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201120711D0 (en) |
| WO (1) | WO2013079215A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9726661B2 (en) * | 2012-07-06 | 2017-08-08 | Institut Gustave-Roussy | Simultaneous detection of cannibalism and senescence as prognostic marker for cancer |
| WO2014018683A2 (en) * | 2012-07-24 | 2014-01-30 | Cedars-Sinai Medical Center | A novel method to detect resistance to chemotherapy in patients with lung cancer |
| CN110662844A (en) | 2017-05-22 | 2020-01-07 | 内盖夫生物技术国家研究所有限公司 | Biomarkers for diagnosis of lung cancer |
| CN112159661B (en) * | 2020-08-31 | 2022-09-27 | 南昌航空大学 | Preparation method and application of rare earth upconversion fluorescent probe for detecting DNA damage markers |
| CN113096730B (en) * | 2021-04-02 | 2022-02-25 | 中山大学 | Prediction system for nasopharyngeal carcinoma molecular typing |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631211A (en) | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5503978A (en) | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
| US5654151A (en) | 1990-06-11 | 1997-08-05 | Nexstar Pharmaceuticals, Inc. | High affinity HIV Nucleocapsid nucleic acid ligands |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| JP4531132B2 (en) | 1995-06-02 | 2010-08-25 | ギリード・サイエンシズ・インコーポレーテッド | High affinity oligonucleotide ligands for growth factors |
| WO1998035012A2 (en) | 1997-02-12 | 1998-08-13 | Chan Eugene Y | Methods and products for analyzing polymers |
| US6403311B1 (en) | 1997-02-12 | 2002-06-11 | Us Genomics | Methods of analyzing polymers using ordered label strategies |
| DE69838521T2 (en) | 1997-07-07 | 2008-05-21 | Medical Research Council | Method for increasing the concentration of nucleic acid molecules |
| US6790671B1 (en) | 1998-08-13 | 2004-09-14 | Princeton University | Optically characterizing polymers |
| US6263286B1 (en) | 1998-08-13 | 2001-07-17 | U.S. Genomics, Inc. | Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer |
| US6210896B1 (en) | 1998-08-13 | 2001-04-03 | Us Genomics | Molecular motors |
| GB9900298D0 (en) | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
| US6818395B1 (en) | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
| US6762059B2 (en) | 1999-08-13 | 2004-07-13 | U.S. Genomics, Inc. | Methods and apparatuses for characterization of single polymers |
| US6696022B1 (en) | 1999-08-13 | 2004-02-24 | U.S. Genomics, Inc. | Methods and apparatuses for stretching polymers |
| AU7086800A (en) | 1999-08-30 | 2001-03-26 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | High speed parallel molecular nucleic acid sequencing |
| GB0022458D0 (en) | 2000-09-13 | 2000-11-01 | Medical Res Council | Directed evolution method |
| US7194269B2 (en) | 2000-10-30 | 2007-03-20 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Industry | Method and wireless communication hub for data communications |
| GB0127564D0 (en) | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
| CA2513535C (en) | 2003-01-29 | 2012-06-12 | 454 Corporation | Bead emulsion nucleic acid amplification |
| US8048627B2 (en) | 2003-07-05 | 2011-11-01 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| WO2005039389A2 (en) | 2003-10-22 | 2005-05-06 | 454 Corporation | Sequence-based karyotyping |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20060019264A1 (en) | 2003-12-01 | 2006-01-26 | Said Attiya | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| CA2553833C (en) | 2004-01-28 | 2012-10-02 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
| EP1735626A2 (en) | 2004-04-16 | 2006-12-27 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases |
| US20100273711A1 (en) * | 2007-09-28 | 2010-10-28 | Anil Potti | Individualized cancer treatments |
-
2011
- 2011-12-01 GB GBGB1120711.5A patent/GB201120711D0/en not_active Ceased
-
2012
- 2012-11-30 WO PCT/EP2012/004957 patent/WO2013079215A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013079215A1 (en) | 2013-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102013015147A8 (en) | method for selecting an algorithm for use in hyperspectral data processing | |
| GB201302725D0 (en) | Methods of graph processing | |
| AU2018256508A1 (en) | Individualized vaccines for cancer | |
| GB2511017A (en) | Providing a malware analysis using a secure malware detection process | |
| MY201637A (en) | Natural killer cells and ilc3 cells and uses thereof | |
| WO2013014667A3 (en) | System and methods for computerized machine-learning based authentication of electronic documents including use of linear programming for classification | |
| GB201120711D0 (en) | Method for classifying tumour cells | |
| EP2650780A3 (en) | Component discovery from source code | |
| IN2014MN01809A (en) | ||
| BR112016026575A2 (en) | Mirna Expression Signature in Thyroid Tumor Classification | |
| EP4585701A3 (en) | Methods and materials for assessing homologous recombination deficiency | |
| EP2485428A3 (en) | Efficient, remote, private tree-based classification using cryptographic techniques | |
| WO2014028453A3 (en) | Natural killer cells and uses thereof | |
| MX2020011767A (en) | Individualized vaccines for cancer. | |
| WO2013102026A3 (en) | Method and system for video composition | |
| GB201301447D0 (en) | Classification reliability prediction | |
| WO2014085776A3 (en) | Web search ranking | |
| EP2913782A4 (en) | FREE FINANCIAL SERVICE DEVICE, BANK NOTE RECOGNITION MODULE, AND RECONNAISSANCE METHOD THEREOF | |
| EP2605182A3 (en) | High-security biometric authentication system | |
| EP2991003A3 (en) | Method and apparatus for classification | |
| WO2012109202A3 (en) | Methods and apparatus for processing documents | |
| Wang et al. | Fuzzy partition based soft subspace clustering and its applications in high dimensional data | |
| IN2014DN08017A (en) | ||
| WO2014145751A3 (en) | Targeted therapies for cancer | |
| EP3780661A3 (en) | Metadata-preserved audio object clustering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |